Mr. Dickman is President and CEO of Prime Therapeutics. Prime Therapeutics is a Pharmacy Benefit Management company in the United States and provides pharmacy services to 15 million Americans. In addition, Prime provides services to nearly 1 million covered seniors under Medicare Part D. Prime Therapeutics is privately held by 15 BlueCross and BlueShield plans. Mr. Dickman has been CEO and a Director since 2002.
Prior to joining Prime Therapeutics, Mr. Dickman was the Pharmacy Practice leader for Tillinghast Towers Perrin, an international consulting firm providing services to employers and insurers in the United States and internationally. He has worked with many of the Fortune 50 companies in the United States and consulted internationally on Pharmacy with several large insurers.
Mr. Dickman has also held executive management positions with Vivra, The Travelers Group, and the Lutheran General Health System in Chicago. He holds a B.S. degree in Pharmacy from Purdue University and a MBA degree from the University of Chicago. Mr. Dickman is a licensed pharmacist in several states.